Navigation Links
Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program
Date:11/11/2008

ogy that enhances safety and efficacy over that of traditional light-based aesthetic treatments. Our work has already helped many people around the world. This program enables participants to benefit from years of research and continue development of an important new approach."

"Investing in innovation is key to the success of Reliant Technologies and it is imperative that Reliant protect the value of its inventions," said Eric Stang, president and CEO of Reliant Technologies. "By forming this FTOPP in conjunction with Palomar and MGH, we are making it possible for companies to access and take advantage of fundamental intellectual property in the fractional space."

"Palomar is recognized as a technology leader with one of the strongest intellectual property portfolios and patent enforcement strategies in the industry," said Joe Caruso, president and CEO of Palomar Medical Technologies. "The FTOPP presents a compelling collection of intellectual property assets that are necessary to operate in the fractional space. We believe companies exploiting fractional technology will find it in their interest to take an FTOPP license and not risk the consequences of infringing such a large number of patents."

The FTOPP comprises six patent families, including eleven issued and pending U.S. patents and applications, along with foreign counterparts. Included in the FTOPP from Reliant are: U.S. patent numbers 6,632,219 and 6,059,820 and patent application number 11/250,139 (the "Tankovich-Baranov" patent family named for early inventors in the fractional space Dr. Nikolai Tankovich and Dr. Eugene Baranov); U.S. patent application number 10/542,390 (the "1678" patent family licensed by Reliant from MGH); and U.S. patent application number 10/367,582 (the "582" patent family). Included in the FTOPP from Palomar Medical Technologies are: U.S. patent number 6,997,923 and patent application number 11/235,697 (the "923" patent family -- jointly owned with and licens
'/>"/>

SOURCE Reliant Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism
2. GSK to Acquire Reliant Pharmaceuticals
3. Thermage and Reliant Technologies to Join Forces
4. Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant
5. Thermage Reports Third Quarter Financial Results and Provides Information Regarding Reliants Results
6. Palomar Medical Technologies and Reliant Technologies Announce Launch of a Fractional Technology Licensing Program
7. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
8. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
9. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
10. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
11. ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products
Post Your Comments:
*Name:
*Comment:
*Email: